Ceridian HCM Holding Inc (CDAY) Expected to Announce Quarterly Sales of $196.63 Million

Wall Street analysts expect that Ceridian HCM Holding Inc (NYSE:CDAY) will post sales of $196.63 million for the current quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Ceridian HCM’s earnings, with the highest sales estimate coming in at $198.01 million and the lowest estimate coming in at $196.10 million. The firm is expected to report its next earnings report on Monday, February 4th.

On average, analysts expect that Ceridian HCM will report full year sales of $742.73 million for the current year, with estimates ranging from $742.20 million to $744.11 million. For the next fiscal year, analysts forecast that the company will report sales of $810.05 million, with estimates ranging from $774.70 million to $828.80 million. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that follow Ceridian HCM.

Ceridian HCM (NYSE:CDAY) last announced its earnings results on Monday, October 29th. The company reported $0.05 EPS for the quarter, topping the Zacks’ consensus estimate of $0.02 by $0.03. The business had revenue of $179.60 million during the quarter, compared to the consensus estimate of $176.29 million. Ceridian HCM had a negative net margin of 2.25% and a positive return on equity of 2.64%. The firm’s quarterly revenue was up 9.8% compared to the same quarter last year.

A number of equities analysts have commented on CDAY shares. William Blair upgraded shares of Ceridian HCM from a “market perform” rating to an “outperform” rating in a report on Friday, August 10th. Citigroup reduced their target price on shares of Ceridian HCM from $38.00 to $35.00 and set a “neutral” rating for the company in a report on Friday, August 10th. Canaccord Genuity reiterated a “hold” rating and issued a $36.00 target price on shares of Ceridian HCM in a report on Friday, August 10th. Guggenheim started coverage on shares of Ceridian HCM in a report on Monday, August 20th. They issued a “buy” rating and a $45.00 target price for the company. Finally, Barclays boosted their target price on shares of Ceridian HCM from $35.00 to $36.00 and gave the stock an “equal weight” rating in a report on Friday, September 7th. Nine analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Ceridian HCM has an average rating of “Hold” and a consensus price target of $39.86.

In other news, CFO Arthur Gitajn sold 135,755 shares of the business’s stock in a transaction dated Tuesday, October 23rd. The stock was sold at an average price of $36.18, for a total transaction of $4,911,615.90. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Cannae Holdings, Inc. sold 4,396,694 shares of the business’s stock in a transaction dated Friday, November 16th. The stock was sold at an average price of $34.70, for a total value of $152,565,281.80. The disclosure for this sale can be found here. Insiders have sold 4,953,737 shares of company stock worth $174,328,418 in the last 90 days.

Hedge funds have recently modified their holdings of the company. JS Capital Management LLC purchased a new stake in shares of Ceridian HCM during the second quarter worth about $6,638,000. BlackRock Inc. purchased a new stake in shares of Ceridian HCM during the second quarter worth about $28,814,000. Waddell & Reed Financial Inc. purchased a new stake in shares of Ceridian HCM during the second quarter worth about $20,880,000. Mackay Shields LLC purchased a new stake in shares of Ceridian HCM during the second quarter worth about $1,286,000. Finally, K2 Principal Fund L.P. purchased a new stake in shares of Ceridian HCM during the second quarter worth about $2,906,000. Institutional investors and hedge funds own 70.02% of the company’s stock.

Ceridian HCM stock traded up $0.10 during trading hours on Friday, reaching $40.12. The stock had a trading volume of 743,423 shares, compared to its average volume of 1,153,538. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.43. Ceridian HCM has a 52 week low of $28.65 and a 52 week high of $44.98.

About Ceridian HCM

Ceridian HCM Holding, Inc engages in the provision of human capital management services. It operates through Human Capital Management (HCM), and LifeWorks segments. The Human Capital Management segment includes cloud solutions, dayforce and powerplay, as well as bureau HCM solutions. The LifeWorks segment reflects the results of LifeWorks joint venture.

Featured Story: Outstanding Shares and The Effect on Share Price

Get a free copy of the Zacks research report on Ceridian HCM (CDAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Ceridian HCM (NYSE:CDAY)

Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit